Ann: H1 2018 Investor Presentation, page-3

H2 FY18 – ship and install first MEG sale

H1 FY19 – Secure second and possibly third MEG sales ( 7 mil up to 12 mil in revenue only from MEG)

FY19– gain FDA for MEG in US for clinical application Outcome

CMP expects to double sales in FY20 to 4 to 5 MEG systems for about USD20m ( sound good to me)

CONFIRMING and reaffirming OUTLOOK numbers for FY18 All seems to be pointing to a change in SP direction.

With the high possibility of further MEG sales, significant future lift in revenue,.

We may be starting an uptrend, there is So much potential in CMP the like of Nexsus 360 cloud sleep diagnostic systems, they are are adding more places in the USA

somfit is another potential,

there is the talk of a spin-off, for some of the IP accumulated over 30 years in R&D, just to unlock frozen wealth

I would like to believe that CMP is regaining its Mojo after a disappointing HY result, the MEG story is becoming a near reality.
the company has so much to offer and benefit the well being of our future health

Something Big will happen, Hopefully, Sooner than late